ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.

February 25, 2000

Medicare Coverage For Clinical Trials Tops NBCC Agenda

January 30, 1998

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983